Evergreen Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
2,649
-149
| -5% | -$66.3K | 0.04% | 334 |
|
|
2025
Q1 | $1.36M | Buy |
2,798
+259
| +10% | +$126K | 0.05% | 292 |
|
|
2024
Q4 | $1.02M | Sell |
2,539
-101
| -4% | -$40.7K | 0.03% | 332 |
|
|
2024
Q3 | $1.23M | Buy |
2,640
+4
| +0.2% | +$1.86K | 0.04% | 307 |
|
|
2024
Q2 | $1.24M | Buy |
2,636
+220
| +9% | +$103K | 0.04% | 284 |
|
|
2024
Q1 | $1.01M | Buy |
2,416
+12
| +0.5% | +$5.02K | 0.04% | 292 |
|
|
2023
Q4 | $978K | Sell |
2,404
-52
| -2% | -$21.2K | 0.04% | 297 |
|
|
2023
Q3 | $854K | Sell |
2,456
-11
| -0.4% | -$3.83K | 0.04% | 304 |
|
|
2023
Q2 | $868K | Buy |
2,467
+939
| +61% | +$330K | 0.04% | 306 |
|
|
2023
Q1 | $481K | Buy |
1,528
+60
| +4% | +$18.9K | 0.02% | 383 |
|
|
2022
Q4 | $424K | Buy |
1,468
+18
| +1% | +$5.2K | 0.02% | 400 |
|
|
2022
Q3 | $420K | Buy |
1,450
+448
| +45% | +$130K | 0.02% | 371 |
|
|
2022
Q2 | $283K | Sell |
1,002
-167
| -14% | -$47.2K | 0.01% | 435 |
|
|
2022
Q1 | $305K | Buy |
1,169
+231
| +25% | +$60.3K | 0.01% | 476 |
|
|
2021
Q4 | $206K | Buy |
+938
| New | +$206K | 0.01% | 591 |
|
|
2020
Q3 | – | Sell |
-741
| Closed | -$215K | – | 438 |
|
|
2020
Q2 | $215K | Buy |
+741
| New | +$215K | 0.02% | 351 |
|